Chimera Investment Corporation’s Review Post Q1 Results
<p>RBC Capital analysts provided a review on <a href='https://financialmodelingprep.com/financial-summary/CIM'>Chimera Investment Corporation (NYSE:CIM) </a>post Q1 earnings, released at the start of the month, with diluted EPS coming in at $0.39, above the Street estimate of $0.37. Similar to other mortgage REIT peers, the company reported a significant BVPS (book value per share) decline (14.3% quarter-over-quarter) on rising rates and MBS spread widening. </p>
<p>According to the analysts, housing fundamentals remain supportive of mortgage credit, though the company's investment strategy could enable it to take advantage of opportunities within agency MBS. </p>
<p>The analysts adjusted their 2022 EPS to $1.43 from $1.53, and their 2023 EPS to $1.41 from $1.53. As a result, their price target was lowered to $11 from $15, while the outperform rating was reiterated.</p>

NYSE:CIM